(
out of
106
reviews
)
Clinical Locations
Primary Location
Huntsman Cancer Institute - Cancer Research North
2D, Hematology
2000 Circle of Hope
Salt Lake City
,
UT
84112
Specialties
- Chronic Lymphocytic Leukemia
- Mantle Cell Lymphoma
- Non-Hodgkin Lymphoma
Board Certification
|
American Board of Internal Medicine (Sub: Hematology)
American Board of Internal Medicine (Sub: Medical Oncology)
National Board of Medical Examiners
American Board of Internal Medicine (Internal Medicine)
|
Patient Rating
5.0
/5
( out of
106 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Assistant Professor (Clinical) |
|---|---|
| Academic Divisions |
Hematology & Hematologic Malignancies
|
| Board Certification |
American Board of Internal Medicine (Sub: Hematology)
American Board of Internal Medicine (Sub: Medical Oncology)
National Board of Medical Examiners
American Board of Internal Medicine (Internal Medicine)
|
Education history
| Undergraduate | Major: Biology; Minor: Chemistry - University of Pittsburgh | B.S. |
|---|---|---|
| Professional Medical | Medicine - St. George's University School of Medicine | M.D. |
| Residency | Internal Medicine - Creighton University School of Medicine | Resident |
| Residency | Internal Medicine - Creighton University School of Medicine | Chief Resident |
| Fellowship | Hematology/Oncology - Huntsman Cancer institute, University of Utah School of Medicine | Fellow |
| Fellowship | Hematology/Oncology - Huntsman Cancer institute, University of Utah School of Medicine | Administrative Chief Fellow |
Selected Publications
Journal Article
- Ermann D, Vardell V, Zacholski E, Fegley A, Modi D, Fedak K, Sundaram S, Rajeeve S, Goyal G, Hatic H, Torka P, Ba Aqeel S, Borogovac A, MacDougall K, Kothari S, Kress A, Travers E, Chilakamarri N, Brem E, Ayyappan S, Sigmund A, Bond D, Fitzgerald L, Wagner C, Hu B, Stephens DM, Shah (2026). Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma. Clinical lymphoma, myeloma & leukemia,
- Pierce AL, Okcu I, Nowakowski G, Tolu S, Amengual J, Ross C, Graber J, Bock A, Hu B, Ermann (2025). HSR25-185: A Multicenter Retrospective Study of Treatment and Survival Outcomes of Patients With Secondary CNS Relapsed DLBCL in the Modern Era. Journal of the National Comprehensive Cancer Network, 23(3.5),
- Baron K, Anto E, Esther J, Vardell VA, Pappas L, Bock A, Ermann DA, Fitzgerald LA, Hu B, Shah H (2025). Comparison of Real-World Outcomes in Patients with Follicular Lymphoma treated with BR vs RCHOP-like regimens. Clinical lymphoma, myeloma & leukemia,
- Baron K, Anto E, Esther J, Vardell VA, Pappas L, Bock A, Ermann DA, Fitzgerald LA, Hu B, Shah H (2025). Comparison of Real-World Outcomes in Patients With Follicular Lymphoma Treated With BR Versus RCHOP-Like Regimens. Clinical lymphoma, myeloma & leukemia,
- Stephens DM, Stewart C, Avruch L, Coombs CC, Danilov A, Hill B, Shadman M, Gerrie A, Jensen CE, Hoffmann M, Winter A, Ermann DA, Barr PM, O'Brien S, Koffman B, Byrd J (2025). Feasibility of Bruton's Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient Perspective. Clinical lymphoma, myeloma & leukemia,
- Dranitsaris G, Peevyhouse A, Neuhalfen H, Dietz LA, Huynh C, Wahlstrom SK, Thompson SL, Teschemaker A, Shetty V, Narkhede M, Ermann D, Blau (2025). A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. Journal of medical economics, 29(1), 30-40.
- Samples L, Voutsinas JM MPH, Fakhri B, Khajavian S, Spurgeon SE, Stephens DM, Skarbnik AP, Mato AR, Broome C, Gopal AK, Smith SD, Lynch RC, Rainey MA, Kim MS, Barrett-Campbell O, Hemond E, Tsang M, Ermann DA, Malakhov N, Rao D, Shakib-Azar M, Morrigan B, Chauhan A, Plate T, Gooley TA, Ryan K, Lansigan F, Hill BT, Pongas G, Parikh SA, Roeker LE, Allan JN, Cheng R, Ujjani C, Shadman (2024). Hypertension Treatment in Patients Receiving Ibrutinib: A Multicenter Retrospective Study. Blood advances,
- Soumerai JD, Barrientos JC, Ahn IE, Coombs CC, Gladstone DE, Hoffmann MS, Kittai AS, Jacobs RW, Lipsky A, Patel K, Rhodes JM, Skarbnik AP, Thompson MC, Ermann DA, Reville PK, Shah HR, Brown JR, Stephens D (2024). Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL. Blood advances,
- Vardell VA, Ermann DA, Tantravahi SK, Haaland B, McClune B, Godara A, Mohyuddin GR, Sborov D (2023). Impact of academic medical center access on outcomes in multiple myeloma. American journal of hematology, 98(1), 41-48.
- Ermann DA, Vardell VA, Shah H, Fitzgerald L, Tao R, Gaffney DK, Stephens DM, Hu (2023). Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy. Clinical lymphoma, myeloma & leukemia, 24(2), 94-104.e6.
- Wagner CB, Boucher K, Nedved A, Micallef IN, Desai S, Hatic H, Goyal G, Zacholski E, Fegley A, Sigmund AM, Bond DA, Samuels C, Kamdar MK, Ba Aqeel S, Torka P, MacDougall K, Borogovac A, Rajeeve S, Sundaram S, Fedak K, Modi D, Travers E, Ayyappan S, Chilakamarri N, Brem EA, Ermann DA, Fitzgerald LA, Hu B, Stephens DM, Shah (2023). Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes. Haematologica, 108(11), 3025-3032.
- Major A, Cliff ERS, Ermann DA, Durani U, Russler-Germain DA (2022). Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressions. EJHaem, 3(3), 930-935.
- Shadman M, Voutsinas J, Fakhri B, Khajavian S, Spurgeon S, Stephens D, Skarnbik A, Mato A, Broome C, Gopal A, Smith S, Lynch R, Rainey M, Kim S, Barrett-Campbell O, Hemond E, Tsang M, Ermann D, Malakhov N, Rao D, Shakib Azar M, Morrigan B, Chauhan A, Plate T, Gooley T, Ryan K, Lansigan F, Hill B, Pongas G, Parikh S, Roeker L, Allan J, Cheng R, Ujjani, C (2022). Treatment of Hypertension In Patients Receiving BTK Inhibitors: A Multicenter Retrospective Study. HemaSphere, 6(), 573-574.
- Ermann DA, Vardell VA, Kallam A, Silberstein PT, Armitage JO (2020). Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis. Clin Lymphoma Myeloma Leuk, 20(4), e174-e183.
- Vardell Noble V, Ermann DA, Griffin EK, Silberstein PT (2019). Primary Thyroid Lymphoma: An Analysis of the National Cancer Database. Cureus, 11(2), e4088.
- Ermann DA, Noble VV, Fazeel HM, Thomas B, Silberstein PT (2019). Presentation of a Rare Malignancy: Leiomyosarcoma of the Prostate. Fed Pract, 36(Suppl 1), S30-S33.
- Pierce TP, Ermann D, Scillia AJ, Festa A, Emami A, McInerney VK (2019). National Trends in Orthopaedic Surgery Resident Adult Case Logs. J Surg Educ, 76(3), 893-897.
Book Chapter
- Baskaran J, Ermann DA, Silberstein P (2019). Myeloproliferative Neoplasms.
- Pinjala A, Ermann DA, Valenta (2019). Pancoast Tumor.
- Ermann DA, Krishnan M, Valenta (2018). Pancoast Tumor.
Commentary
- Ermann DA, and Kittai A (2024). Richter Transformation of Chronic Lymphocytic Leukemia Is a Challenging Clinical Scenario Requiring a Personalized Approach. ASCO Daily News.
Letter
- Vardell VA, Ermann DA, Fitzgerald L, Shah H, Hu B, Stephens D (2024). T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments. American journal of hematology, 99(3), 494-496.
- Vardell VA, Ermann DA, Fitzgerald LA, Shah HR, Hu B, Stephens D (2023). Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia. American journal of hematology, 98(7), E172-E174.
Abstract
- Ermann DA, Dranitsaris G, Blau S, Peevyhouse A, Neuhalfen H, Wahlstrom SK, Thompson SL, Teschemaker A, Shetty V, Narkhede M (2025). A real-world comparative analysis of cardiovascular (CV) safety and time to next treatment (TTNT) with acalabrutinib versus ibrutinib in treatment-naive patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). 2025 ASCO Annual Meeting. Chicago, IL. 43(16 (Supplement)),
- Steven M. Bair, Mayur Narkhede, Zachary AK Frosch, Elise A. Chong, Daniel A. Ermann, Iris Isufi, Farrukh T. Awan, Julio C Chavez, Grace N Bosma, and Diana Abbot (2023). Treatment Intensity and Outcomes in Elderly Patients with DLBCL Receiving First Line Therapy.
- Sanjal H. Desai, Nuttavut Sumransub, Rich Evans, Marcus P Watkins, Reem Karmali, MD, Gaurav Goyal, Mitchell E. Hughes, Arushi Khurana, Francisco J. Hernandez-Ilizaliturri, Joanna Zurko, Ayesha Hassan, Haris Hatic, Imran A. Nizamuddin, Andrew M Evens, Andrea Carolina Anampa-Guzmán, Yi Lin, MD, Iris Isufi, Mehdi Hamadani, Saurabh A Rajguru, Naveena Lall, Aung M. Tun, Brian T. Hill, Deborah M. Stephens, Paolo F. Caimi, Daniel A. Ermann, Brad S. Kahl, Daniel J. Landsburg, and Grzegorz S. Nowakowsk (2023). Improved Survival of R/R Double Hit/Triple Hit Lymphoma in the Era of CD19 Chimeric Antigen T Cell (CART) Therapy.
He is super smart and focused with a kindly personality. And he is very good looking. You can quote me.
Doctor Ermann has been a trusted physician. Clear, direct and caring.
Very accomplished and able to share information in an understandable form. Seemed interested in me as an individual and very thourgh and kind.
Over a long period of treatments, Dr Ermann and his team have always been very responsive, professional and caring about me personally.
I was referred to Doctor Ermann based on his interest and knowledge concerning my illness. Easy to talk to and express my anxiety. He listens and does his best to be clear.
professional
He is very concerned with what I am going through, he explains things so I can understand. I appreciate him very much!
Dr. Ermann is extremely thorough and kind. He explained everything to me clearly so that there was no panic or confusion and made sure to answer all of my questions. If you are looking for care I highly recommend Dr. Ermann. I am grateful for have Dr. Ermann on my team.
Dr. Ermann is Avery good listener and explains medical issues and conditions calmly and simply. He talks to patients directly while refraining from being to intense
Dr Ermann, is very through, listens and a very kind and understanding doctor.
He truly cares about his patients
Very through and professional, takes time to explain everything to you in a way you can understand
He is very positive person very kind and good matters
Excellent.explained options, appreciate that is is very current with CLL treatment and research, very caring
Careing.
Dr Ermann is very thorough, covers all the bases,.listens to my concerns carefully and addresses all the issues.
Very good
He's a very positive man with a very engaging personality and explains everything very well!
Dr Ermann is someone you want to have on your team
Genuine caring physician with a strong educational knowledge base.
I think the doctor's care is very good. [TRANSLATED]
Dr. ERMANN very kind and makes you feel at ease, easy to understand.
Dr. Ermann is one smart Doctor that knows his stuff and is trying to make a difference. I feel safe with his decisions.
Dr. Ermann is a skilled and knowledgeable doctor and is always willing to help and answer questions.
Dr. Ermann is Amazing and I would recommend him to anyone I knew that was diagnosed with CLL or SLL.
I feel comfortable talking with him. He's got a plain and so far it seems to be going quite well.
Dr Ermann is a caring and very knowledgeable physician. You can tell he cares about all of his patients. I am fortunate to have him caring for my condition.
Dr Ermann is very thorough, personable and knowledgeable. Great experience, highly recommend.
Dr. Ermann is extremely knowledgeable and is patient in explaining what he thinks is the best treatment for my cancer. I trust is judgement and skills.
Dr. Ermann is the very best. He's so knowledgeable, so kind,very patient and kind. I'm so lucky to be a patient of his. I wouldn't want any one else. Thank Dr. Ermann.
Dr ermann always takes time to answer and explain things in a way we can understand
Dr. Ermann is a very knowledgeable and caring professional who treats you with respect and concern. Not too many physicians will call you directly with the results of the testing - he did several times.
Dr. Ermann is great. Answered all my questions.
Presents himself in a very professional manner and is a good listener. Felt comfortable with him providing an initial evaluation of my condition and gave me clear understanding of what was to be done.
I have a high regard for Dr Ermann as a CLL specialist very knowledgeable.
Dr. Ermann is very thorough and answered all my many questions completely and made me feel completely at ease and informed about my newly diagnosed CLL. I would highly recommended him to anyone dealing with this type of cancer!
Iwouldnt want any other Dr. For my care.
My wife and I were both impressed and grateful for the personal time Dr Ermann spent with us discussing my treatment options in a very easy to understand manner and answered our every question without making us feel hurried on unheard. By the end of our discussion, we were all in agreement that the best treatment plan for me had been identified, selected, and completely understood.
Dr Ermann is a very caring and knowledgeable doctor. I am very comfortable in his care
Very smart doctor
Fantastic doctor. Explained everything very clearly and listened to our concerns.
My first visit with Dr Ermann. He was very nice, informative and knowledgeable about my condition.
Dr. Ermann showed genuine concern for my well being and clearly answered all my questions.
When I first saw the doctor he was very polite. He had very good aura about him. I felt comfortable around him. He was very knowledgeable, intelligent, clean and he allowed me to speak and ask questions and he answered them to the way I could understand him. Thank you, Dr. Daniel Arthur erdman
Dr Ermann explained things to me in a way I could understand. I felt listened to and validated.
Amazing doctors
It was a lot to take in, but he was very patient. Very caring and explain things quite well.
Dr Ermann has been very diligent and thoughtful in finding out everything that is going on with me. It has been complex but he has never given up in trying to get to the bottom of it all. I am very appreciative for everything he has done for me.
Professional
My doctor has been Deborah Stephens who recently left. I was so worried about her replacement. I'm thrilled to be in the care of Dr. Ermann as my oncologist. I have a lot of trust in him. I just hope he stays with me.
A wonderful, caring doctor
Thanks again, Dr. Ermann. I look forward to our next visit, and becoming more educated regarding (CLL) [NAME REMOVED]
Excellent! He explains things well, is kind snd takes time to listen to me.
Dr. Ermann is the doctor I trust to take care of my CLL related issues. He is awesome.
Dr. Ermann has all the qualities of a knowledgeable and concerned physician for his patients.
He came in on time, was very attentive and addressed every concern.
Dr. Ermann is a very professional physician who is very detailed about your medical care and is a great listener.
If you have lymphoma, Dr Ermann is who you want taking care of you. Not only does he genuinely care and listen, but he's darn smart! He just caught a very rare occurrence in my blood that has saved me a lot of discomfort and possible heart damage. And he caught it very quickly. He never feels like he's rushing and is very attentive and includes me in the discussion. I can't say enough about Dr. Ermann. I trust him with my life and he and the BMT team basically saved my life.
Thanks for all the work he did with me awesome doctor
He very knowledgeable and can explain things in a way we understand. He is compassionate and kind and we are grateful.
Kind, knowledgeable, genuine. He took time to answer questions and explain options as well as the cancer
He is a very knowledgeable in his field. Kind and honest about the details
I just Love Dr. Ermann, he has taken care of me since I was first diagnosed with CLL. He is very caring and explains everything to me. He takes the time to listen to me. Dr. Ermann is tops in my book!
Good listener. Great bedside manner. Explains things well. Not rushed with his time spent with patient. Very knowledgeable of disease.
Pleasant and speaks in laymen's terms that can be understood and has full control of treating his specialty.
He is a very caring and sympathetic doctor I hope he never loses that
Excellent! Listens and takes time time to answer questions.
Dr. Ermann is a very caring kind Doctor and always has the time to address my needs.
What can I say about a person that saved my life. Dr. Ermann is the best
Dr. Ermann is a good doctor. I didn't choose him. Dr. Stephens did. She knew me very well and I can see why she chose him for me. He's very smart, kind, listens well and understands my medical history and we're in agreement on future care. I'm very pleased and feel I'm in good hands.
Dr Ermann was compassionate, knowledgeable, and kind. He is a wonderful addition to Huntsman.
Very Good and caring.
Dr. Ermann was very kind, answered all our questions and was very knowledgeable. We felt comfortable in a scary situation and we appreciated the time he took with us.
Dr Ermann and his staff are very through in their procedures, have a comfortable bedside manner of treatment, and very knowledgeable in their treatment.
Dr Ermann was very friendly, listened to my concerns, and was very knowledgeable about my condition.
Great ¿bedside manner¿. Empathetic . Listens as well as trying to make sure the patient umderstands
Was always kind towards me and answered my questions when I became curious about certain topics around cancer and the treatment. I imagine answering those for every patient every time can become exhausting.
He was wonderful.
Very caring and professional and nice to look at!
Dr Ermann if very thorough and patient. He is compassionate and spends the time needed to answer questions.
I expected a full court press to urge me to transfer care to HCI but Dr. Ermann was fair and considerate in his evaluation of my past care, offered options, and explained pros of HCI. I had been dreading this visit expecting it to be awkward but it totally accepting and encouraging.
Dr. Ermanns expertise was obvious at our first meeting. His manner of care, and the thorough way he explained my diagnosis and treatments, was very reassuring to me and my husband.